Alfacell Corporation
Records under this name other than patents Alfacell Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,229,824 | Ribonucleases and Methods of Making Them Recombinantly Formerly held Term ended Term ended May 24, 2024 · High confidence | Term ended | Term ended May 24, 2024 | High confidence |
| US 7,763,449 | Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long Formerly held Term ended Term ended Aug 27, 2023 · High confidence | Term ended | Term ended Aug 27, 2023 | High confidence |
| US 7,442,535 | Fusion Protein Incorporating a Cysteinized Ribonuclease Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |
| US 7,442,536 | Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |
| US 7,473,542 | Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |
| US 7,556,951 | Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |
| US 7,556,952 | Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of a Known Amino Acid Sequence and an Initial N-Terminal Residue Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |
| US 7,556,953 | Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |
| US 7,585,654 | Nucleic Acid Encoding Cysteinized Ribonuclease to Which a Targeting Moiety Can Be Conjugated Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |
| US 7,585,655 | Nucleic Acid Encoding a Fusion Protein Incorporating a Cysteinized Ribonuclease Formerly held Term ended Term ended Jul 17, 2023 · High confidence | Term ended | Term ended Jul 17, 2023 | High confidence |